Telotristat ethyl (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Telotristat ethyl" in English language version.

refsWebsite

Global rank English rank

447^th place

338^th place

low place

low place

1,712^th place

1,063^rd place

4^th place

4^th place

68^th place

117^th place

2^nd place

2^nd place

canada.ca

"Drug and medical device highlights 2018: Helping you maintain and improve your health". Health Canada. 14 October 2020. Retrieved 17 April 2024.

doi.org

Kulke M, Hörsch D, Caplin M, Anthony L, Bergsland E, Oberg K, et al. (1 October 2016). "Integrated Placebo-Controlled Safety Analysis from Clinical Studies of Telotristat Ethyl for the Treatment of Carcinoid Syndrome". Annals of Oncology. 27 (6): 136–48. doi:10.1093/annonc/mdw369.07.

europa.eu

ema.europa.eu

"Xermelo EPAR". European Medicines Agency (EMA). Retrieved 17 April 2020.

fda.gov

fda.gov

"FDA Approves Xermelo for Carcinoid Syndrome Diarrhea" (Press release). U.S. Food and Drug Administration (FDA). February 28, 2017. Retrieved 1 March 2017.
New Drug Therapy Approvals 2017 (PDF). U.S. Food and Drug Administration (FDA) (Report). January 2018. Retrieved 16 September 2020.

accessdata.fda.gov

"Xermelo (telotristat ethyl) Tablets". U.S. Food and Drug Administration (FDA). 4 April 2017. Retrieved 17 April 2020.

hres.ca

hpr-rps.hres.ca

"Summary Basis of Decision (SBD) for Xermelo". Health Canada. 23 October 2014. Retrieved 29 May 2022.

nih.gov

dailymed.nlm.nih.gov

"Xermelo- telotristat ethyl tablet". DailyMed. 30 October 2020. Retrieved 11 November 2020.